Pfizer (PFE +1.25%) has reached deep into the heart of Europe for its latest product buy. The company announced that a Polish subsidiary has acquired the rights to Polocard, a low-dose aspirin, from ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced that a wholly-owned Polish subsidiary of Pfizer has acquired the rights to Polocard, a low-dose aspirin (acidum acetylsalicylicum), ...
Pfizer announced that a wholly-owned Polish subsidiary of Pfizer has acquired the rights to Polocard, a low-dose aspirin and the leading over-the-counter brand for heart attack prevention in Poland, ...
NEW YORK — Pfizer on Monday announced that a wholly-owned Polish subsidiary of Pfizer has acquired the rights to Polocard, a low-dose aspirin (acidum acetylsalicylicum), and the leading ...
Pfizer says that it has acquired the rights to Polocard, a low-dose aspirin and the leading over-the-counter brand for heart attack prevention in Poland. Pfizer says that it has acquired the rights to ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced that a wholly-owned Polish subsidiary of Pfizer has acquired the rights to Polocard, a low-dose aspirin (acidum acetylsalicylicum), ...
Pfizer has reached deep into the heart of Europe for its latest product buy. The company announced that a Polish subsidiary has acquired the rights to Polocard, a low-dose aspirin, from local ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results